Search
for
Sort by
Research 301–330 of 339
- The Anti-atopic Lotions Containing Fucoidan Extracted from Ecklonia Cava Impact on Hairless Mice Atopic Dermatitis Skin
- Ganoderma lucidum extract attenuates corticotropin-releasing hormone induced cellular senescence in human hair follicle cells
- White Lupin Cluster Root Acclimation to Phosphorus Deficiency and Root Hair Development Involve Unique Glycerophosphodiester Phosphodiesterases
- Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata
- Editorial: Untangle the broad connections and tight interactions between human microbiota and complex diseases through data-driven approaches, volume II
- Exosomal microRNA-Based therapies for skin diseases
- Fibroblasts in Diabetic Foot Ulcers
- ENZYMES
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Dedicator of Cytokinesis 5 Regulates Keratinocyte Function and Promotes Diabetic Wound Healing
- MINOXIDIL ORAL E SUA EFICÁCIA NO TRATAMENTO DA ALOPECIA
- Polycystic ovary syndrome
- Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia
- GLP‐1 agonists and hair loss: a call for further investigation
- Hair and Scalp Effects of GLP-1 Receptor Agonists in Practice
- Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Maternal obesity and the metabolic syndrome in reproductive health: assessing incretin-based interventions
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- Editor's Highlights — September 2024
- Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus
- Fast-tracked innovation: orforglipron approval under the FDA’s National Priority Voucher program
- Farmácia da Boa Hora, Porto e nos Serviços Farmacêuticos do Hospital Lusíadas, Porto
- Faculty Opinions recommendation of Stem cell niche exit in C. elegans via orientation and segregation of daughter cells by a cryptic cell outside the niche.
- THU372 Finasteride Induced Hyperglycemia
- Polycystic ovary syndrome: pragmatic management across levels of care
- Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats